Masanori Umeda
- Co-authors
- Nozomi NiitsuYoshio HonmaJunko Okabe‐KadoYuri Yamamoto-YamaguchiTakashi KasukabeKatsutomo SasakiNaoki WakimotoAkiko Sakashita
- Topics
- Lymphoma Diagnosis and Treatment (14 papers)Acute Myeloid Leukemia Research (12 papers)Hematological disorders and diagnostics (10 papers)
In The Last Decade
Masanori Umeda
53 papers receiving 515 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 275
- Oncology 145
- Pathology and Forensic Medicine 139
- Hematology 113
- Genetics 68
Countries citing papers authored by Masanori Umeda
This map shows the geographic impact of Masanori Umeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Umeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Umeda more than expected).
Fields of papers citing papers by Masanori Umeda
This network shows the impact of papers produced by Masanori Umeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Umeda. The network helps show where Masanori Umeda may publish in the future.
Co-authorship network of co-authors of Masanori Umeda
This figure shows the co-authorship network connecting the top 25 collaborators of Masanori Umeda. A scholar is included among the top collaborators of Masanori Umeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanori Umeda. Masanori Umeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Six cases of therapy-related leukemia or myelodysplastic syndrome after treatment for solid cancer | 0 |
| 2 | 14 | |
| 3 | 5 | |
| 4 | 29 | |
| 5 | 29 | |
| 6 | 14 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | [Clinical usefulness of 123I-BMIPP (beta-methyl iodophenyl pentadecanoic (acid) myocardial SPECT in patients with hematological malignancies with adriamycin-induced cardiomyopathy]. | 0 |
| 12 | 8 | |
| 13 | 5 | |
| 14 | 6 | |
| 15 | 9 | |
| 16 | 4 | |
| 17 | [Clinical usefulness of 123I-MIBG myocardial SPECT in patients with adriamycin-induced cardiomyopathy]. | 5 |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 16 |
About Masanori Umeda
Masanori Umeda is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 59 papers that have together received 533 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Acute Myeloid Leukemia Research (12 papers) and Hematological disorders and diagnostics (10 papers). The work is most often cited by research in Hematology (113 citations), Pathology and Forensic Medicine (139 citations) and Genetics (68 citations). Masanori Umeda has collaborated with scholars based in Japan, Australia and Italy. Frequent co-authors include Nozomi Niitsu, Yoshio Honma, Junko Okabe‐Kado, Yuri Yamamoto-Yamaguchi, Takashi Kasukabe, Katsutomo Sasaki, Naoki Wakimoto, Akiko Sakashita, Yuri Yamaguchi and Nobuo Maseki. Their work appears in journals such as Blood, Biochemical and Biophysical Research Communications and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.